AU6600190A - Therapeutic compositions; methods for treatment of hiv infections - Google Patents

Therapeutic compositions; methods for treatment of hiv infections

Info

Publication number
AU6600190A
AU6600190A AU66001/90A AU6600190A AU6600190A AU 6600190 A AU6600190 A AU 6600190A AU 66001/90 A AU66001/90 A AU 66001/90A AU 6600190 A AU6600190 A AU 6600190A AU 6600190 A AU6600190 A AU 6600190A
Authority
AU
Australia
Prior art keywords
treatment
methods
therapeutic compositions
hiv infections
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66001/90A
Inventor
Jonathon W Uhr
Ellen S. Vitetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU6600190A publication Critical patent/AU6600190A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU66001/90A 1989-09-14 1990-09-14 Therapeutic compositions; methods for treatment of hiv infections Abandoned AU6600190A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40747989A 1989-09-14 1989-09-14
US407479 1989-09-14
US51924090A 1990-05-03 1990-05-03
US519240 1990-05-03

Publications (1)

Publication Number Publication Date
AU6600190A true AU6600190A (en) 1991-04-18

Family

ID=27019894

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66001/90A Abandoned AU6600190A (en) 1989-09-14 1990-09-14 Therapeutic compositions; methods for treatment of hiv infections

Country Status (5)

Country Link
EP (1) EP0491873A4 (en)
JP (1) JPH05502218A (en)
AU (1) AU6600190A (en)
CA (1) CA2065029A1 (en)
WO (1) WO1991004050A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407068B1 (en) 1992-11-05 2002-06-18 Lagrone Robert P. Method of treating humans with diseases characterized by high secretion of cytokines from macrophage cells
US5981493A (en) * 1992-11-05 1999-11-09 Lagrone; Robert P. Method of treating humans infected with human immunodeficiency virus
AU4497199A (en) * 1998-04-15 1999-11-08 Ingrid-Corina Bergter Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections
US20030099621A1 (en) * 2001-11-29 2003-05-29 Robert Chow Stem cell screening and transplantation therapy for HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
PT88641B (en) * 1987-10-02 1993-04-30 Genentech Inc METHOD FOR PREPARING A VARIETY OF ADHESION
WO1990004414A1 (en) * 1988-10-18 1990-05-03 Biogen, Inc. Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection

Also Published As

Publication number Publication date
CA2065029A1 (en) 1991-03-15
WO1991004050A1 (en) 1991-04-04
EP0491873A4 (en) 1992-10-28
JPH05502218A (en) 1993-04-22
EP0491873A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
GB8821049D0 (en) Method & composition for treatment & prevention of viral infections
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
AU600264B2 (en) Treatment of fungal infections
AU1193288A (en) Composition for treatment of acne
AU6518890A (en) 6-amino-1,2-benzopyrones useful for treatment of viral diseases
ZA90245B (en) Treatment of diseases associated with hiv infections
AU4530989A (en) Pharmaceutical composition for the treatment of cerebral edema
AU5185790A (en) Treatment of tibial dyschondroplasia
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU5568290A (en) Method of suppressing hiv infection
AU5953090A (en) Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents
AU6660090A (en) Treatment of depression
AU6796287A (en) Method and composition for prophylaxis and treatment of viral infections
AU7515287A (en) Methods and compositions for treating viral infections
AU6600190A (en) Therapeutic compositions; methods for treatment of hiv infections
AU3027692A (en) Compositions for the treatment of mammalian diseases
AU4328189A (en) Bile acids for treatment of viral infections
AU3189989A (en) Process for the treatment of concrete
AU7737991A (en) Medical uses of m-csf
AU1541088A (en) Composition for the treatment of the epiderm
AU4829190A (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
AU8497191A (en) Compositions and methods for treating hiv infections
AU1792788A (en) Rubradirin derivatives for treatment of hiv infection
AU636421B2 (en) Method for the treatment of glaucoma